Published in BMJ on July 22, 2006
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*. Multidiscip Respir Med (2014) 0.97
Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes (2007) 0.94
End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis (2008) 0.90
Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry. Medicine (Baltimore) (2016) 0.78
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ (2003) 2.40
International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J (2006) 1.74
Scoring system and clinical application of COPD diagnostic questionnaires. Chest (2006) 1.66
ABC of palliative care. Breathlessness, cough, and other respiratory problems. BMJ (1997) 1.07
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother (2005) 7.42
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
Privatising primary care. Br J Gen Pract (2006) 3.68
The public health implications of world trade negotiations on the general agreement on trade in services and public services. Lancet (2003) 3.52
The future of peptide-based drugs. Chem Biol Drug Des (2013) 3.41
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ (2003) 2.93
Antibiotic prescribing and outcomes of lower respiratory tract infection in UK primary care. Chest (2009) 2.35
Family medicine in 2018. Can Fam Physician (2010) 2.24
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med (2009) 2.17
Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med (2006) 2.10
COPD screening efforts in primary care: what is the yield? Prim Care Respir J (2007) 2.03
Screening for and early detection of chronic obstructive pulmonary disease. Lancet (2009) 1.99
No evidence that patient choice in the NHS saves lives. Lancet (2011) 1.96
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol (2004) 1.88
Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ (2012) 1.87
Role of living liver donation in the United Kingdom. BMJ (2003) 1.82
General practitioners with a special clinical interest: a model for improving respiratory disease management. Br J Gen Pract (2002) 1.80
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol (2008) 1.76
The market in primary care. BMJ (2007) 1.73
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol (2009) 1.70
Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability. Prim Care Respir J (2007) 1.67
Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim Care Respir J (2009) 1.66
The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J (2009) 1.64
A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther (2013) 1.61
Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61
Clinical trials and tribulations: the MASCOT study. Thorax (2011) 1.59
New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med (2011) 1.56
Functional coupling of capping and transcription of mRNA. Mol Cell (2002) 1.56
Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial. Br J Gen Pract (2005) 1.53
Professional and patient attitudes to using mobile phone technology to monitor asthma: questionnaire survey. Prim Care Respir J (2006) 1.52
The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J (2009) 1.51
Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51
New deal from the World Trade Organisation. BMJ (2003) 1.49
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (2007) 1.49
The national montelukast survey. J Allergy Clin Immunol (2005) 1.47
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Arch Intern Med (2003) 1.44
Mid Staffordshire should lead to a fundamental rethink of government policy. BMJ (2013) 1.41
How the secretary of state for health proposes to abolish the NHS in England. BMJ (2011) 1.40
GOLD COPD categories are not fit for purpose in primary care. Lancet Respir Med (2013) 1.37
Pro-con debate: Inhaled corticosteroids should not be prescribed in primary care to children under two years of age - the case for. Prim Care Respir J (2008) 1.37
Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics (2005) 1.36
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc (2014) 1.32
Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis (2009) 1.32
EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J (2008) 1.31
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain (2012) 1.25
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol (2009) 1.25
Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med (2006) 1.24
Questions for COPD diagnostic screening in a primary care setting. Respir Med (2005) 1.23
Current control and future risk in asthma management. Allergy Asthma Immunol Res (2011) 1.22
How the Health and Social Care Bill 2011 would end entitlement to comprehensive health care in England. Lancet (2012) 1.22
Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med (2010) 1.20
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg (2002) 1.20
An exploratory, pragmatic, cluster randomised trial of practice nurse training in the use of asthma action plans. Prim Care Respir J (2007) 1.19
Chronic obstructive pulmonary disease. BMJ (2003) 1.17
British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med (2008) 1.14
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer (2003) 1.13
Best cases from the AFIP: omental lymphangioma with small-bowel volvulus. Radiographics (2003) 1.13
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol (2012) 1.13
Befriending carers of people with dementia: randomised controlled trial. BMJ (2008) 1.12
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med (2009) 1.10
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.08
Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study. Respir Res (2007) 1.08
The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J (2005) 1.07
UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J (2010) 1.07
Comparing virtual consults to traditional consults using an electronic health record: an observational case-control study. BMC Med Inform Decis Mak (2012) 1.07
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection. AIDS (2002) 1.05
A flawed Bill with a hidden purpose. Lancet (2012) 1.05
Extending choice in the NHS. BMJ (2002) 1.05
Can a GP be a generalist and a specialist? Stakeholders views on a respiratory General Practitioner with a special interest service in the UK. BMC Health Serv Res (2006) 1.04
Health and Social Care Bill 2011: a legal basis for charging and providing fewer health services to people in England. BMJ (2012) 1.04
From support to boundary: a qualitative study of the border between self-care and professional care. Patient Educ Couns (2009) 1.03
General practitioners with a special interest in respiratory medicine: national survey of UK primary care organisations. BMC Health Serv Res (2005) 1.02
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. J Allergy Clin Immunol (2013) 1.02
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Poor communication may impair optimal asthma care: a qualitative study. Fam Pract (2006) 0.99
The use of a modification of the Patient Enablement Instrument in asthma. Prim Care Respir J (2007) 0.99
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc (2015) 0.98
Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol (2002) 0.97
Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim Care Respir J (2010) 0.97
Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997-2001. Int J Chron Obstruct Pulmon Dis (2006) 0.96
Guidelines for allergic rhinitis need to be used in primary care. Prim Care Respir J (2009) 0.96
Planning for closure: the role of special administrators in reducing NHS hospital services in England. BMJ (2013) 0.96
The CYMPLA trial. Mobile phone-based structured intervention to achieve asthma control in patients with uncontrolled persistent asthma: a pragmatic randomised controlled trial. Prim Care Respir J (2009) 0.94
Exacerbations of chronic obstructive pulmonary disease--a patients' perspective. Prim Care Respir J (2006) 0.94
What happens to patients who have their asthma device switched without their consent? Prim Care Respir J (2010) 0.92
Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J (2006) 0.92
Database studies in asthma pharmacoeconomics: uses, limitations and quality markers. Expert Opin Pharmacother (2003) 0.91
Distinct mechanisms produce functionally complementary actions of neuropeptides that are structurally related but derived from different precursors. J Neurosci (2010) 0.91
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis. Int Arch Allergy Immunol (2013) 0.91
Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade. J Pharmacol Toxicol Methods (2006) 0.91
The discovery of novel calcium sensing receptor negative allosteric modulators. Bioorg Med Chem Lett (2009) 0.90
The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J (2007) 0.89
Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study. Prim Care Respir J (2012) 0.88
The BREATHE study: Breathing REtraining for Asthma--Trial of Home Exercises. a protocol summary of a randomised controlled trial. Prim Care Respir J (2013) 0.88
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc (2012) 0.87
The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient management. Prim Care Respir J (2009) 0.87